Skip to main content
Journal cover image

Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH)

Publication ,  Conference
Harrison, SA; Goodman, ZD; Ratziu, V; Loomba, R; Diehl, AM; Lawitz, E; Hinrichsen, H; Bambha, K; Abdelmalek, MF; Myers, RP; Schall, REA ...
Published in: HEPATOLOGY
October 1, 2015

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2015

Volume

62

Start / End Page

910A / 910A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harrison, S. A., Goodman, Z. D., Ratziu, V., Loomba, R., Diehl, A. M., Lawitz, E., … Muir, A. J. (2015). Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). In HEPATOLOGY (Vol. 62, pp. 910A-910A). San Francisco, CA: WILEY-BLACKWELL.
Harrison, Stephen A., Zachary D. Goodman, Vlad Ratziu, Rohit Loomba, Anna Mae Diehl, Eric Lawitz, Holger Hinrichsen, et al. “Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH).” In HEPATOLOGY, 62:910A-910A. WILEY-BLACKWELL, 2015.
Harrison SA, Goodman ZD, Ratziu V, Loomba R, Diehl AM, Lawitz E, et al. Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 910A-910A.
Harrison, Stephen A., et al. “Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH).” HEPATOLOGY, vol. 62, WILEY-BLACKWELL, 2015, pp. 910A-910A.
Harrison SA, Goodman ZD, Ratziu V, Loomba R, Diehl AM, Lawitz E, Hinrichsen H, Bambha K, Abdelmalek MF, Myers RP, Schall REA, Subramanian M, McHutchison JG, Afdhal NH, Muir AJ. Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 910A-910A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2015

Volume

62

Start / End Page

910A / 910A

Location

San Francisco, CA

Publisher

WILEY-BLACKWELL

Conference Name

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics